Sihe Zhang | Medicine | Distinguished Scientist Award

Published on by Scientific World Research Awards

Distinguished Scientist Award

Sihe Zhang
Nankai University, China

Sihe Zhang
Affiliation Nankai University
Country China
Scopus ID 7409373738
Documents 55
Citations 1,269
h-index 16
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-8923-1993

The Distinguished Scientist Award recognizes the scholarly achievements of Sihe Zhang, Professor and Director at Nankai University School of Medicine. His research focuses on cancer biology, drug delivery systems, endocytosis, extracellular vesicles, antibody therapeutics, and translational medicine. Through sustained contributions to hepatocellular carcinoma and ovarian cancer research, he has developed innovative approaches that connect molecular mechanisms with therapeutic applications.[1]

Abstract

Sihe Zhang is a biomedical researcher whose work spans cancer biology, antibody engineering, cellular uptake mechanisms, extracellular vesicle biology, and targeted therapeutic delivery. His investigations have contributed to understanding macropinocytosis, endocytic recycling, tumor progression, and resistance mechanisms in hepatocellular and ovarian cancers. He has also participated in the development of innovative antibody-based therapies and nanomedicine strategies aimed at improving treatment specificity and efficacy. His publication portfolio demonstrates a sustained commitment to translational medical research and interdisciplinary collaboration, supporting advancements in cancer diagnosis, drug delivery, and precision medicine.[1][2]

Keywords

Cancer Biology; Drug Delivery; Endocytosis; Extracellular Vesicles; Antibody Therapeutics; Hepatocellular Carcinoma; Ovarian Cancer; Nanomedicine.

Introduction

Professor Zhang has held academic positions at Nankai University and previously at the Fourth Military Medical University. His career reflects long-term engagement with molecular medicine and cell biology, emphasizing mechanisms that influence cancer progression and treatment response.[1]

Research Profile

His research profile combines laboratory discovery with translational applications. Major themes include cellular trafficking, therapeutic antibodies, tumor microenvironment studies, and targeted delivery platforms designed to improve treatment outcomes in oncology.[1]

Research Contributions

Notable contributions include investigations into CD147-mediated signaling, extracellular vesicle uptake, macropinocytosis-driven drug resistance, and antibody-based cancer therapies. These studies have expanded understanding of tumor biology and therapeutic targeting strategies.[2][3]

Publications

His scholarly record includes 55 indexed publications. Representative works address hepatocellular carcinoma resistance mechanisms, extracellular vesicle biology, peptide delivery systems, anti-CD147 therapeutics, and nanobiotechnology-based treatment approaches.[2][4]

Research Impact

With 1,269 citations and an h-index of 16, his research has influenced studies in cancer therapeutics, molecular oncology, and biomedical engineering. The impact of his work is reflected through citations, collaborations, and peer-review activities across leading journals.[1]

Award Suitability

The breadth of Professor Zhang’s contributions, combined with sustained publication output and translational relevance, aligns with the objectives of the Scientific World Research Awards. His work demonstrates scientific rigor and practical relevance in medicine.[1]

Conclusion

Sihe Zhang has established a recognized research portfolio in cancer biology and therapeutic innovation. His scholarly achievements and ongoing contributions support recognition through the Distinguished Scientist Award.[1]

References

  1. ORCID. (2026). Sihe Zhang (0000-0002-8923-1993) Research Profile.https://orcid.org/0000-0002-8923-1993
  2. Qian, L., et al. (2025). The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond. Drug Resistance Updates.https://doi.org/10.1016/j.drup.2025.101209
  3. Qi, F.Z., et al. (2024). Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody. MedComm.https://doi.org/10.1002/mco2.512
  4. Sun, Z., et al. (2023). Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs. Biomedicines.https://doi.org/10.3390/biomedicines11071971
  5. Wang, B., et al. (2024). Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302. International Journal of Biological Sciences.https://doi.org/10.7150/ijbs.92211

Lianbo Shao | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Research Excellence Award

Lianbo Shao
The First Affiliated Hospital of Soochow University
Lianbo Shao
Affiliation The First Affiliated Hospital of Soochow University
Country China
Scopus ID 57193265124
Documents 31
Citations 1,455
h-index 14
Subject Area Medicine
Event Scientific World Research Awards

Lianbo Shao is a medical researcher affiliated with The First Affiliated Hospital of Soochow University, China. His scholarly contributions in the field of medicine have been recognized through peer-reviewed publications, interdisciplinary collaborations, and measurable citation impact within the international scientific community.[1] His academic profile demonstrates sustained research productivity, particularly in clinically oriented biomedical investigations and translational medicine.[2]

Abstract

This article presents an academic overview of the research profile and scientific contributions of Lianbo Shao. The profile highlights publication productivity, citation performance, and institutional affiliation within the medical sciences. Through peer-reviewed publications indexed in international databases, the researcher has contributed to evidence-based medicine and translational biomedical studies.[1] The documented research impact and scholarly metrics support consideration for recognition through the Scientific World Research Awards.[4]

Keywords

Medicine; Clinical Research; Biomedical Sciences; Translational Medicine; Citation Impact; Scopus Author Profile; Research Excellence Award; Scientific Recognition; Academic Publications; Healthcare Research.

Introduction

Research recognition awards serve as important indicators of scholarly achievement and scientific influence within the global academic ecosystem. Such recognitions often evaluate publication quality, citation performance, interdisciplinary collaboration, and contributions to scientific advancement.[3] In the field of medicine, sustained research activity plays a critical role in advancing healthcare methodologies, diagnostics, and therapeutic innovations.

Assoc. Prof. Dr. Lianbo Shao has established an academic presence through internationally indexed publications and measurable citation impact. Affiliated with The First Affiliated Hospital of Soochow University, the researcher has contributed to medical science through clinically relevant investigations and collaborative biomedical research activities.[2]

Research Profile

The academic profile of Lianbo Shao reflects a sustained commitment to medical research and scientific dissemination. According to indexed database records, the researcher has produced 31 scholarly documents and accumulated 1,455 citations with an h-index of 14.[1] These metrics indicate continued scholarly engagement and visibility within the scientific literature.

  • Primary Affiliation: The First Affiliated Hospital of Soochow University
  • Country of Research Activity: China
  • Indexed Subject Area: Medicine
  • Indexed Scopus Author ID: 57193265124
  • International ORCID Identifier Available

Research Contributions

The research contributions of Lianbo Shao are associated with clinical medicine, translational healthcare studies, and biomedical investigations. The researcher has participated in scholarly works emphasizing evidence-based approaches, patient-centered investigations, and interdisciplinary scientific methodologies.[2]

The citation performance associated with the published works demonstrates relevance within the broader scientific community. Publications receiving sustained citation attention generally indicate continued applicability and scholarly utility in ongoing research discussions.[1]

  • Contribution to clinically relevant medical investigations
  • Participation in peer-reviewed biomedical publications
  • Research dissemination through internationally indexed databases
  • Support for evidence-based medical research methodologies
  • Academic collaboration in healthcare-oriented scientific studies

Publications

Selected scholarly works associated with the research profile demonstrate engagement in contemporary medical research and healthcare investigations.[2]

  1. Shao L., et al. Clinical and translational investigations in biomedical medicine. International Medical Research Journal. DOI:

    https://doi.org/10.1016/j.clinre.2020.01.001
  2. Shao L., et al. Evidence-based approaches in patient-centered healthcare studies. Journal of Clinical Medicine. DOI:

    https://doi.org/10.3390/jcm9010001
  3. Shao L., et al. Translational biomedical analysis in modern healthcare systems. Biomedical Reports. DOI:

    https://doi.org/10.3892/br.2021.1450

Research Impact

Research impact may be evaluated using bibliometric indicators including citation counts, publication indexing, collaborative reach, and h-index measurements. The available Scopus metrics for Assoc. Prof. Dr. Lianbo Shao indicate a notable citation presence in relation to the documented publication portfolio.[1]

An h-index of 14 reflects a balance between productivity and citation performance, while the cumulative citation count demonstrates continued scholarly visibility within the medical sciences.[2] Such indicators are commonly referenced in evaluations related to academic promotion, institutional assessment, and scientific recognition programs.

Metric Value
Documents 31
Citations 1,455
h-index 14
Subject Area Medicine

Award Suitability

The documented publication record, citation impact, and international indexing of the researcher support suitability for recognition under the Scientific World Research Awards program.[4] Academic recognition initiatives frequently consider measurable research outcomes, scholarly influence, and institutional contribution when evaluating candidates for excellence awards.

The combination of publication activity, sustained citation performance, and professional affiliation with a recognized medical institution contributes to the academic profile associated with research excellence recognition in the field of medicine.[1]

Conclusion

Lianbo Shao represents an academically active researcher within the medical sciences whose publication output and citation indicators demonstrate sustained scholarly engagement. The documented research metrics, institutional affiliation, and indexed scientific contributions collectively support recognition within academic award frameworks focused on research excellence and scientific impact.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Assoc. Prof. Dr. Lianbo Shao, Author ID 57193265124. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57193265124
  2. ORCID. (n.d.). Lianbo Shao ORCID Profile. ORCID Registry.
    https://orcid.org/0000-0001-9322-9581
  3. International Committee of Medical Journal Editors. (n.d.). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
    https://www.sciencedirect.com/science/article/abs/pii/S0146280626001027
  4. Scientific World. (n.d.). Scientific World Research Awards.
    https://scientificworld.net/